(2-Bromo-1-methyl-1H-imidazol-5-yl)methanol, 98%, 1g

tert-Butyl methyl[2-(methylamino)ethyl]carbamate, 97.0%, 100g

1-Cyclopropyl-4-oxocyclohexanecarbonitrile, 95.0%, 250mg

Adamantan-1-yl(cyclohexyl)(2',4',6'-triisopropyl-3,6-dimethoxy-[1,1'-biphenyl]-2-yl)phosphane, 250mg

3-Chloro-5-(2,2,2-trifluoroethoxy)pyridazine, 95.0%, 10g

6-tert-butyl 8-ethyl 6-azaspiro[3.4]octane-6,8-dicarboxylate, 97.0%, 100mg

Developing chambers for TLC, Suitable for, up to 2 plates up to 10 x 10 cm plate size, 1 Piece(s)

(S)-2-Isopropyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 97%, 1g

2-[(1R,2R)-2-benzyloxy-1-methyl-propoxy]-4-chloro-5-(trifluoromethyl)pyrimidine, 98%, 250mg

3-(2-fluorophenyl)-4-methyl-4,5-dihydro-1H-1,2,4-triazole-5-thione, 90%, 10g

5,6-Dimethoxypicolinaldehyde, 95.0%, 5g

1-(4-(aminomethyl)phenyl)ethan-1-one hydrobromide, 95.0%, 1g

3-(3-Bromophenyl)propionic acid, 98.0%, 5g